Naomi Walsh joined the Technology Commercialization group in 2019 initially as a Fellow and is now a Licensing Officer specializing in the transfer and commercialization of Life Science Research Tools including cell lines, antibodies and mouse strains.
Prior to working in Technology Commercialization, Naomi completed her doctoral and post-doctoral work at University of Wisconsin—Madison, where she focused on fungal pathogens and antifungal drug development. During this time, she also participated in business courses and workshops, was formally trained in writing Small Business Innovation Research Grants (SBIRs), and worked as an independent consultant for local biotech startups. Enthusiastic about appropriately protecting innovations, Naomi has pursued formal education in intellectual property law through engaging in law courses, attending IP conferences, and passing the patent bar exam.
Naomi is a registered patent agent and holds a PhD in biochemistry from UW—Madison and a BS in biochemistry from right here at UMN.